HuGE Literature Finder
Records
1
-
19
| Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis. Human immunology 2021 Nov . Dhouioui Sabrine, Laaribi Ahmed-Baligh, Boujelbene Nadia, Jelassi Refka, Ben Salah Hamza, Bellali Hedia, Ouzari Hadda-Imene, Mezlini Amel, Zemni Inès, Chelbi Hanene, Zidi In |
| Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer. Human vaccines & immunotherapeutics 2021 Mar 1-11. Yu Yaojun, Zhang Jing, Ni Leyi, Zhu Yuesheng, Yu Hejie, Teng Yangyang, Lin Limiao, Xue Zhanxiong, Xue Xiangyang, Shen Xian, Song Haiping, Su Xiaoping, Sun Weihong, Cai Zhenzh |
| Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets. BioMed research international 2020 2020 2861240. Chen Chao, Liu Songming, Qu Ruokai, Li |
| Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. Histopathology 2019 May . Barrow P, Richman S D, Wallace A, Handley K, Hutchins G G A, Kerr D, Magill L, Evans D G, Gray R, Quirke P, Hill |
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.
Gastroenterology 2018 Dec . Lu Yingchang, Kweon Sun-Seog, Tanikawa Chizu, Jia Wei-Hua, Xiang Yong-Bing, Cai Qiuyin, Zeng Chenjie, Schmit Stephanie L, Shin Aesun, Matsuo Keitaro, Jee Sun Ha, Kim Dong-Hyun, Kim Jeongseon, Wen Wanqing, Shi Jiajun, Guo Xingyi, Li Bingshan, Wang Nan, Zhang Ben, Li Xinxiang, Shin Min-Ho, Li Hong-Lan, Ren Zefang, Oh Jae Hwan, Oze Isao, Ahn Yoon-Ok, Jung Keum Ji, Conti David V, Schumacher Fredrick R, Rennert Gad, Jenkins Mark A, Campbell Peter T, Hoffmeister Michael, Casey Graham, Gruber Stephen B, Gao Jing, Gao Yu-Tang, Pan Zhi-Zhong, Kamatani Yoichiro, Zeng Yi-Xin, Shu Xiao-Ou, Long Jirong, Matsuda Koichi, Zheng W |
| Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer discovery 2018 Mar . Grasso Catherine S, Giannakis Marios, Wells Daniel K, Hamada Tsuyoshi, Mu Xinmeng Jasmine, Quist Michael, Nowak Jonathan A, Nishihara Reiko, Qian Zhi Rong, Inamura Kentaro, Morikawa Teppei, Nosho Katsuhiko, Abril-Rodriguez Gabriel, Connolly Charles, Escuin-Ordinas Helena, Geybels Milan S, Grady William M, Hsu Li, Hu-Lieskovan Siwen, Huyghe Jeroen R, Kim Yeon Joo, Krystofinski Paige E, Leiserson Mark Dm, Montoya Dennis J, Nadel Brian B, Pellegrini Matteo, Pritchard Colin C, Puig-Saus Cristina, Quist Elleanor H, Raphael Benjamin J, Salipante Stephen J, Shin Daniel Sanghoon, Shinbrot Eve, Shirts Brian, Shukla Sachet, Stanford Janet L, Sun Wei, Tsoi Jennifer, Upfill-Brown Alexander, Wheeler David A, Wu Catherine J, Yu Ming, Zaidi Syed H, Zaretsky Jesse M, Gabriel Stacey B, Lander Eric S, Garraway Levi A, Hudson Thomas J, Fuchs Charles S, Ribas Antoni, Ogino Shuji, Peters Ulri |
| KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 01 24 (1): 224-233. Lal Neeraj, White Brian S, Goussous Ghaleb, Pickles Oliver, Mason Mike J, Beggs Andrew D, Taniere Philippe, Willcox Benjamin E, Guinney Justin, Middleton Gary |
| HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer. International journal of molecular sciences 2017 Jun 18 (7): . Garziera Marica, Virdone Saverio, De Mattia Elena, Scarabel Lucia, Cecchin Erika, Polesel Jerry, D'Andrea Mario, Pella Nicoletta, Buonadonna Angela, Favaretto Adolfo, Toffoli Giusep |
| KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer. Human immunology 2017 Jan . Portela Pâmela, Merzoni Joice, Lindenau Juliana D, Damin Daniel C, John Wilson Timothy, Roesler Rafael, Schwartsmann Gilberto, Fernando Jobim Jobim Luiz Maria |
| Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight. International journal of immunogenetics 2016 Feb 43 (1): 32-9. Garziera M, Catamo E, Crovella S, Montico M, Cecchin E, Lonardi S, Mini E, Nobili S, Romanato L, Toffoli |
| The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population. Genetic testing and molecular biomarkers 2015 Sep . Al Omar Suliman Y, Mansour Lamjed, Dar Javid Ahmed, Alwasel Saleh, Alkhuriji Afrah, Arafah Maha, Al Obeed Omar, Christmas Steph |
| Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer. Cancer immunology, immunotherapy : CII 2015 Mar 64 (3): 357-66. Surmann Eva-Maria, Voigt Anita Y, Michel Sara, Bauer Kathrin, Reuschenbach Miriam, Ferrone Soldano, von Knebel Doeberitz Magnus, Kloor Matthi |
| Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer. JAMA internal medicine 2014 May 174 (5): 732-9. Reimers Marlies S, Bastiaannet Esther, Langley Ruth E, van Eijk Ronald, van Vlierberghe Ronald L P, Lemmens Valery E P, van Herk-Sukel Myrthe P P, van Wezel Tom, Fodde Riccardo, Kuppen Peter J K, Morreau Hans, van de Velde Cornelis J H, Liefers Gerrit J |
| Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. PloS one 2014 9 (1): e84940. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Talamini Renato, Racanelli Vito, D' Andrea Mario, Buonadonna Angela, Zagonel Vittorina, Cecchin Erika, Innocenti Federico, Toffoli Giusep |
| HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients. International journal of surgery (London, England) 2014 12 (8): 815-20. Kim Hyung-Jin, Choi Hae-Baeg, Jang Jung-Pil, Baek In-Cheol, Choi Eun-Jeong, Park Miyoung, Kim Tai-Gyu, Oh Seong-Ta |
| Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer. Medical oncology (Northwood, London, England) 2013 Mar 30 (1): 1. Zhen ZJ, Ling JY, Cai Y, Luo WB, He YJ |
| Efficient association analysis between colorectal cancer and allelic polymorphisms of HLA-DQB1 by comparison of age of onset. Oncology letters 2012 Mar 3 (3): 517-519. Tong Fengzhi, Yu Weijian, Liu H |
| MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer. Oncology reports 2011 Nov 26 (5): 1165-71. Wolkersdörfer Toralf, Füssel Monika, Kiesslich Tobias, Neureiter Daniel, Berr Frieder, Aust Daniela, Wolkersdörfer Gernot |
| MHC Class II alleles in ulcerative colitis-associated colorectal cancer. Gut 2009 Sep 58 (9): 1226-33. Garrity-Park M M, Loftus E V, Sandborn W J, Bryant S C, Smyrk T |
- Page last reviewed:Jul 25, 2022
- Page last updated:Sep 22, 2022
- Content source: